Background: At M phase, cyclin B1 is phosphorylated in the cytoplasmic retention sequence (CRS), which is required for nuclear export. During interphase, cyclin B1 shuttles between the nucleus and the cytoplasm because constitutive nuclear import is counteracted by rapid nuclear export. In M phase, cyclin B moves rapidly into the nucleus coincident with its phosphorylation, an overall movement that might be caused simply by a decrease in its nuclear export. However, the questions of whether CRS phosphorylation is required for cyclin B1 translocation in mitosis and whether a reduction in nuclear export is sufficient to explain its rapid relocalisation have not been addressed.
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Background: At M phase, cyclin B1 is phosphorylated in the cytoplasmic retention sequence (CRS), which is required for nuclear export. During interphase, cyclin B1 shuttles between the nucleus and the cytoplasm because constitutive nuclear import is counteracted by rapid nuclear export. In M phase, cyclin B moves rapidly into the nucleus coincident with its phosphorylation, an overall movement that might be caused simply by a decrease in its nuclear export. However, the questions of whether CRS phosphorylation is required for cyclin B1 translocation in mitosis and whether a reduction in nuclear export is sufficient to explain its rapid relocalisation have not been addressed.
Results:
We have used two forms of green fluorescent protein to analyse simultaneously the translocation of wild-type cyclin B1 and a phosphorylation mutant of cyclin B1 in mitosis, and correlated this with an in vitro nuclear import assay. We show that cyclin B1 rapidly translocates into the nucleus approximately 10 minutes before breakdown of the nuclear envelope, and that this movement requires the CRS phosphorylation sites. A cyclin B1 mutant that cannot be phosphorylated enters the nucleus after the wild-type protein.
Phosphorylation of the CRS creates a nuclear import signal that enhances cyclin B1 import in vitro and in vivo, in a manner distinct from the previously described import of cyclin B1 mediated by importin β.
Conclusions:
We show that phosphorylation of human cyclin B1 is required for its rapid translocation to the nucleus towards the end of prophase. Phosphorylation enhances cyclin B1 nuclear import by creating a nuclear import signal. The phosphorylation of the CRS is therefore a critical step in the control of mitosis.
Background
One of the most important protein kinases in the regulation of mitosis is the complex of cyclin B with its partner catalytic subunit, cyclin-dependent kinase 1 (Cdk1). At each mitosis and meiosis in animal cells, cyclin B1 is phosphorylated on Ser-Pro sites [1] [2] [3] that are evolutionarily conserved, but the consequence of this is unclear. A nonphosphorylatable mutant of cyclin B1 is still able to bind and activate its partner Cdk1, and is degraded at the correct time in mitosis [1, 2] . Experiments assaying the ability of Xenopus cyclin B1 to promote meiotic maturation have demonstrated a requirement for the mitosis-specific phosphorylation sites in the amino terminus of the protein [2, 4] . More specifically, these sites are in the cytoplasmic retention sequence (CRS), which is necessary and sufficient to direct cyclin B1 into the cytoplasm [5] .
One change in cyclin B1 behaviour that correlates with its phosphorylation when cells enter meiosis or mitosis is that it moves from the cytoplasm into the nucleus [6] [7] [8] . This movement is probably connected with the putative role of the cyclin B-Cdk1 complex as the nuclear lamin kinase that causes nuclear envelope disassembly at the end of prophase. Cyclin B1-Cdk1 will phosphorylate the nuclear lamins, both in vitro and in vivo [9] [10] [11] , on residues on either side of the coiled-coil region that are required for disassembly [9, 12] . A mutant form of cyclin B1 in which the phosphorylation sites in the CRS are mutated to nonphosphorylatable alanines is unable to cause Xenopus oocytes to enter meiosis [2, 4] . This mutant did not accumulate in the nuclei of maturing oocytes, but it could be made to cause meiotic maturation by targeting it to the nucleus with a SV40 T-antigen nuclear localisation signal (NLS) [4] . Thus, the ability to enter the nucleus is required for cyclin B1-Cdk1 to promote entry into meiosis, and probably to promote mitosis in somatic cells.
Xenopus extracts [15] . The physiological role of cyclin B1 nuclear export, however, is disputed. There are some data to suggest that an export-defective form of cyclin B1 compromises the DNA-damage checkpoint in G2 phase [14, 16] , whereas other studies suggest that nuclear cyclin B1 can have a protective effect [13, 17] .
When the NES of cyclin B1 is inactivated, or when cells are treated with leptomycin B to inhibit nuclear export, cyclin B1-Cdk1 accumulates in the nucleus [13] [14] [15] . This shows that cyclin B1-Cdk1, or an associated protein, has an NLS and that throughout S and G2 phases the complex must be continuously shuttling between the nucleus and the cytoplasm. Although neither cyclin B nor Cdk1 have a recognisable SV40-like or bipartite NLS [18] , a deletion mutant of Xenopus cyclin B1 that lacked its amino terminus, including the CRS, has been shown to bind directly to importin β [19] .
The identification of an NES in cyclin B1 raises the possibility that its translocation into the nucleus at mitosis and meiosis could simply be a consequence of the inhibition of its nuclear export. Indeed, Xenopus cyclin B1 binds much less exportin 1 in meiotic oocyte extracts [15] . A mutant form of human cyclin B1 with a defective NES takes several hours to accumulate in the nucleus [13] , however, whereas the translocation of wild-type cyclin B1 in prophase takes approximately 10 minutes. This suggests that translocation might also require enhanced nuclear import, perhaps via the importin β pathway. We have used real-time imaging of cyclin B1-green fluorescent protein (GFP) fusion proteins as cells enter mitosis to address the mechanism of translocation. We show that translocation is not simply a consequence of inhibiting export; it also involves the generation of a NLS in the amino terminus through phosphorylation of the CRS. Moreover, this appears to be distinct from the importin β-dependent import signal previously described for cyclin B1.
Results
All five serine residues in the CRS can be phosphorylated in mitotic cell extracts
The CRS of human cyclin B1 contains five serine residues that are in analogous positions to the mitosis-specific phosphorylation sites mapped in Xenopus and sea urchin B-type cyclins [2, 20] (Figure 1a) . To study the importance of cyclin B1 phosphorylation we generated point mutants in which we changed the serine residues in the CRS to either threonine (T) or to non-phosphorylatable alanine (A) residues, expressed them and the wild-type cyclin B1 as glutathione-S-transferase (GST) fusion proteins in bacteria, purified them by affinity chromatography on glutathione-Sepharose, and mixed them with cell lysates Research Paper Translocation of cyclin B1 at mitosis Hagting et al. 681
Figure 1
Cyclin B1 is phosphorylated on conserved phosphorylation sites in the CRS. (a) The CRS regions of human (Hs), Xenopus laevis (X), and the sea urchin Arbacia punctulata (Ap) were aligned by eye. Identical residues are connected with a vertical line and conserved substitutions are marked with an asterisk. The phosphorylation sites in human cyclin B1 are in bold and marked with bullet points. (b) Wild-type cyclin B1, (WT) and a quintuple alanine mutant of the five phosphorylation sites (5×A), were purified as GST-tagged proteins and bound to glutathionecoated Sepharose beads. Cyclin-B1-coated beads were used as an affinity matrix to isolate associated kinase activity from G1/S-and M-phase HeLa cell extracts (each prepared from ~1.5 × 10 6 cells). Cyclin B1 phosphorylation was assayed in vitro in the presence of [γ 32 -P]ATP. Cyclin B1 was cleaved from the GST domain using thrombin, and analysed by SDS-PAGE and autoradiography (top panel). The level of phosphorylation was quantified after analysis on a phosphorimager using Mac Bas software (Fuji; bottom panel). (c) Wildtype cyclin B1 and serine-to-threonine point mutants (S116T, S126T, S128T, S133T and S147T) were purified as GST-tagged proteins and used to isolate associated cyclin B1 kinase activity from G2/M-phase HeLa cell extracts (prepared from ~7 × 10 6 cells). Cyclin B1 phosphorylation was assayed in vitro in the presence of [γ 33 -P]ATP. Cyclin B1 was cleaved from the GST domain using thrombin, and phosphoamino-acid analyses carried out. P i , inorganic phosphate; Ori, origin; S, Serine; T, Threonine. No phosphotyrosine was detectable. from synchronised HeLa cells. The mutants were functional in that they were able to bind Cdk1 and activate it to the same extent as wild type (data not shown). We found wild-type cyclin B1 was much more heavily phosphorylated by an associated kinase activity in mitotic cell extracts than in interphase extracts (Figure 1b) , and, as previously observed for Xenopus cyclin B1 [2] , when we mutated all five serines to alanines (mutant 5×A) we completely eliminated phosphorylation (Figure 1b) . By phosphoamino-acid analysis, human cyclin B1 was shown to be phosphorylated only on serine residues; therefore we made point mutations to change individual serines into threonine residues, and analysed their phosphorylation state by phosphoamino-acid analysis. We found that S126 was the major site of phosphorylation in late G2/M phase extracts ( Figure 1c ). About 50% of the phosphate was incorporated into this site, and the other four sites were phosphorylated to an approximately equal extent. Recently, Meijer and colleagues have shown that in starfish the phosphorylation of cyclin B1 in meiosis is primarily because of autophosphorylation [20] . We found that all five sites in human cyclin B1 could also be autophosphorylated in vitro (data not shown), but we were unable to exclude the possibility that there might be another kinase involved in their phosphorylation in vivo.
Cyclin B1 translocation assayed using fusion proteins containing GFP or yellow fluorescent protein (YFP) that can be distinguished in vivo
To assay the effects of altering the CRS phosphorylation sites on cyclin B1 translocation at mitosis, we set up an assay to distinguish the behaviour of the mutant proteins from the wild type in real time. We constructed fusion proteins between wild-type human cyclin B1 and the F64L/S65T version of GFP (MmGFP, excitation maximum 490 nm, emission maximum 512 nm), and fused the phosphorylation-site mutants of cyclin B1 to YFP [21] (excitation maximum 515 nm, emission maximum 525 nm), and vice versa. We designed a filter set to distinguish between these two mutants ( Figure 2 and see Materials and methods section) and introduced the cDNAs by microinjection into G2-phase cells that had been synchronised by a thymidine and aphidicolin regime. The fusion proteins were visible approximately 3 hours after cDNA microinjection, and were monitored by time-lapse fluorescence microscopy.
We compared the translocation of the cyclin B1 fusion proteins with respect to the time of nuclear envelope breakdown as assayed by both differential interference contrast (DIC) imaging and the time at which TRITC-labelled dextran (molecular weight 70,000 Da) entered the nuclei. We found that the mutant form of cyclin B1 in which we altered all the CRS serine residues to glutamic acids to mimic phosphorylation (mutant 5×E) partially accumulated in the nucleus throughout interphase (Figure 3a ). In contrast, wild-type cyclin B1 was predominantly cytoplasmic throughout G2 phase until it very rapidly translocated into the nucleus over a period of about 6 minutes towards the end of prophase. Translocation began more than 6 minutes before nuclear envelope breakdown as visualised by DIC microscopy ( Figure 3b , bottom row), or by the movement of Texas-Red-labelled dextran into the nucleus ( Figure 3b , middle row). The cyclin B1 phosphorylation mutant in which all the serine residues were altered to alanine residues (5×A), however, translocated significantly later than the wild-type protein, ~3 minutes before Texas Red-dextran entered the nucleus (data not shown, but see below). This suggested that the 5×A mutant might enter the nucleus just before the nuclear envelope began to disassemble, but we noticed that Texas-Red-dextran did not diffuse rapidly within the cell and therefore might not reflect the exact time at which the nuclear envelope became porous. Thus, we made use of a constitutively cytoplasmic protein, a GST-GFP fusion protein linked to the NES of RanBP1 (GG-NES, gift of I. Macara, and see [22] ). This protein does not have a recognisable nuclear import signal and so cannot enter the nucleus even when its nuclear export is inhibited by leptomycin B (Figure 4a ). We found that the 5×A mutant of cyclin B1 and the GG-NES construct entered the nucleus at the same time in mitosis, suggesting that the 5×A mutant of cyclin B1 could only enter the nucleus when the nuclear envelope 682 Current Biology, Vol 9 No 13
Figure 2
Green fluorescent protein and yellow fluorescent protein can be distinguished using the JP3 GFP/YFP filterset. Expression constructs of the cDNAs encoding cyclin B1-GFP or cyclin B1-YFP, driven by the cytomegalovirus (CMV) promoter, were injected into the nuclei of G2-phase HeLa cells. Fluorescence images were taken 4 h after injection with the GFP/YFP filter set, using 250 msec (GFP) and 50 msec (YFP) exposures and a gain of 3 units on the intensifier. . To confirm this, we coexpressed the cyclins with a mutant form of human lamin A in which serine residues crucial to lamin disassembly had been mutated to alanine residues [12] (gift of R. Heald). We reasoned that because this mutant inhibits the disassembly of the nuclear lamina it should increase the time between translocation of wild-type cyclin B1 and the nonspecific entry of protein through the disassembling nuclear lamina. In cells expressing the mutant form of lamin A, the cyclin B1 5×A mutant entered the nuclei more than 6 minutes after the wild-type protein (Figure 4c) . Thus it appears that the CRS of cyclin B1 must be phosphorylated to allow the protein to translocate into the nucleus.
Wild-type cyclin B1 and the 5× ×A mutant differ in their nuclear import rates
Our results suggested that phosphorylation of the CRS in cyclin B1 enhanced its ability to enter the nucleus at the end of prophase. This could be through an effect on nuclear import, or export, or both. To distinguish between these possibilities, we injected wild-type and mutant cyclin B1-GFP cDNA expression constructs into cells and then treated the cells with leptomycin B (gift of M. Yoshida), which blocks exportin-1-mediated nuclear export [23, 24] of cyclin B1 [13] [14] [15] . We found that the 5×E mutant entered nuclei much faster than wild-type cyclin B1 after leptomycin B treatment ( Figure 5 , compare a,c,d).
In contrast, the 5×A mutant of cyclin B1 accumulated in nuclei at a much slower rate (Figure 5b,d ). This suggested that the phosphorylation of the CRS was affecting the ability of cyclin B1 to enter nuclei independently of an effect on its rate of export.
Phosphorylation-dependent nuclear import has been described for a number of proteins. In some cases the protein was released from a cytoplasmic anchor, whereas in other cases, phosphorylation created a nuclear import signal or inhibited nuclear export. To determine the mechanism by which cyclin B1 import was regulated by phosphorylation we used the well characterised in vitro nuclear import system based on permeabilised HeLa cells to which purified nuclear import components can be added to reconstitute nuclear transport [25, 26] . This system has also been used to show that an amino-terminal deletion mutant of Xenopus cyclin B1 lacking its CRS was imported into nuclei by binding directly to importin β [19] . We used the full length cyclin-GFP chimaeras as substrates in the nuclear import assay.
Wild-type cyclin B1-GFP was not significantly imported into nuclei in the presence of interphase cell extract, but its import was greatly enhanced in the presence of mitotic extract (Figure 6a ). In contrast, the 5×A mutant was not imported in the presence of either interphase or mitotic extract (Figure 6a ). These results suggested that cyclin B1 nuclear import was phosphorylation dependent in the in vitro system. To determine whether this effect could be ascribed to proteins in the interphase cell extracts that were masking or anchoring cyclin B1, we assayed cyclin B1 import in the presence of nuclei, ATP and purified nuclear import factors only. Under these conditions, the 5×A mutant was not imported into nuclei, wild-type cyclin B1 was imported to a small extent, and the 5×E mutant was efficiently imported (Figure 6b ). We were able to exclude the possibility that this effect was simply due to a reduction in the export rate of the cyclin because a mutant form of cyclin B1 with a defective NES (F146A) [13] was not imported into nuclei any more efficiently than the wildtype protein (Figure 6b ). Thus, it appeared that altering the phosphorylation state of the CRS had a direct effect on the ability of cyclin B1 to be imported into nuclei.
The amino terminus of cyclin B1 has a phosphorylationdependent nuclear import signal
Given that phosphorylation of the CRS appeared to affect the nuclear import of cyclin B1 in the probable absence of cytoplasmic anchors or masking proteins, we considered the possibility that phosphorylation might have created a nuclear import signal on the amino terminus of cyclin B1.
To test this we fused GFP to the amino terminus of cyclin B1, either to the wild-type protein or to the 5×A or 5×E mutant, and assayed nuclear import in the in vitro system in the presence or absence of purified transport factors. The 5×E amino terminus was able to import GFP into the nucleus, but the 5×A mutant was not (Figure 7a ). These results were also seen when we microinjected these constructs into tissue culture cells (data not shown). Furthermore, importin β was unable to stimulate the import of either the 5xE (Figure 7a ) or the wild-type amino terminus of cyclin B1 linked to GFP under conditions where it did stimulate the import of a SV40 NLS substrate in vitro (Figure 7a ), suggesting that this phosphorylation-dependent import used a different pathway from that described for cyclin B1 without its amino terminus. Like the full-length cyclin B1, the wild-type cyclin B1 amino terminus could import GFP into the nucleus in the presence of mitotic cell extract, but not in the presence of interphase extract (Figure 7b ). Thus, it appears that phosphorylation of the cyclin B1 CRS in mitosis creates a nuclear import signal on its amino terminus that contributes to the rapid translocation of cyclin B1 to the nucleus at the end of prophase.
Discussion
We have shown that the rapid translocation of cyclin B1 into the nucleus at mitosis is regulated by phosphorylation of the CRS. By imaging cyclin B1-GFP fusion proteins in live cells we find that cyclin B1 normally translocates into the nucleus within ~10 minutes. This rapid translocation begins late in prophase, after the nucleoli have disappeared and when chromosome condensation has largely
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Figure 6
The phosphorylation state of the CRS alters cyclin B1 import.
(a) Mitotic cell extract stimulates nuclear import of cyclin B1-GFP. Permeabilised HeLa cells were incubated in 2 mg/ml S-phase or 1.5 mg/ml M-phase HeLa cell extract and an energy-regenerating mixture with either cyclin B1-GFP or cyclin B1 5×A-GFP. After 10 min incubation at 37°C, cells were fixed and nuclear uptake was visualised by confocal fluorescence microscopy. (b) Mutations in the CRS create a constitutive nuclear localisation signal (NLS). Permeabilised HeLa cells were incubated in nuclear import buffer containing 0.2 µM importin β, 0.5 µM Ran-GDP, 0.5 µM NTF2 and an energy-regenerating mixture with 3 µM of either cyclin B1 5×A-GFP, cyclin B1-GFP, cyclin B1 5×E-GFP or a nuclear-export-defective cyclin B1 mutant (F146A)-GFP. After 10 min incubation at 22°C, cells were fixed and nuclear uptake was assayed by confocal fluorescence microscopy. finished. Thus it is possible that the initial nuclear events of prophase are not caused by cyclin B1-Cdk1, but by another protein kinase that is active at the beginning of mitosis. Indeed, we have evidence to suggest that they might depend on cyclin A-CDK complexes (N. Furuno and J.P., unpublished observations). Very soon after cyclin B-Cdk1 has translocated into the nucleus, the nuclear envelope breaks down, and this correlates with the postulated role of cyclin B-Cdk1 as the lamin kinase. Furthermore, in cells that are expressing a non-phosphorylatable lamin, cyclin B1-Cdk1 translocates into the nucleus and then markedly associates with the nuclear periphery, which might be indicative of a stabilised enzyme-substrate interaction (data not shown).
We have been able to visualise two different GFP fusion proteins with a custom filter set that can distinguish the F64L/S65T version of GFP from YFP. This filter set might prove useful to other researchers who are attempting co-localisation studies in living cells, although a sensitive camera is required to acquire the GFP image. With this filter set we show that a mutant of cyclin B1 in which we altered phosphorylation sites in the CRS to alanine residues (5×A) only enters the nucleus once the nuclear envelope begins to break down. Conversely, a mutant in which we altered the sites to glutamic acid residues (5×E), to mimic phosphorylation, gradually accumulates in the nucleus during interphase, but at a very much slower rate than cyclin B1 at mitosis. These differences are also observed in the presence of leptomycin B, which inhibits exportin 1/Crm1-dependent export -including the export of cyclin B1 -suggesting that the mutations are affecting the rate of nuclear import.
We confirmed these results using a purified in vitro nuclear import system. We found that the full-length protein or the amino terminus of cyclin B1 could import GFP into nuclei when the CRS contained the 5×E mutations, but not with the 5×A mutations. Wild-type cyclin B1 or its amino terminus could only import GFP when it was incubated in the presence of mitotic extract. In the in vitro nuclear import system there was very little nuclear export (M.J., unpublished observations), and there was no apparent difference between the wild-type cyclin B1 and a mutant with a defective NES. This further supports our interpretation that these effects were due to changes in the rate of nuclear import and not of export. Furthermore, the opposite effects of the 5×E and 5×A mutants were observed with nuclei, Ran and an energy source only, making it unlikely that the 5×A prevents nuclear import by binding to a cytoplasmic anchor. Thus a nuclear import signal seemed to be created on the amino terminus of cyclin B1 through phosphorylation of the CRS. In interphase, the (5×E) mutation shifted the equilibrium between nuclear and cytoplasmic cyclin B1 towards more cyclin B1 in the nucleus. This suggested that phosphorylation of the cyclin B1 CRS enhanced the import of cyclin B1 in interphase, but that the effect was counteracted by its nuclear export.
A phosphorylation-dependent nuclear localisation signal has recently been described for Dorsal protein [27] , the Rel protein homologue in Drosophila. There is no apparent homology between Dorsal and cyclin B1 in the phosphorylation sites -a protein kinase A site in Dorsal -or in the regions immediately adjacent. Conversely, a cyclin-CDK phosphorylation-dependent nuclear export signal has been 686 Current Biology, Vol 9 No 13
Figure 7
The amino terminus of cyclin B1 acts as a phosphorylation-dependent NLS. (a) Nuclear import of the CRS is independent of importin β. Permeabilised HeLa cells were incubated in nuclear import buffer containing 0.5 µM Ran-GDP, 0.5 µM NTF2 and an energyregenerating mixture with either 3 µM cyclin B1(1-161) 5×A-GFP, cyclin B1(1-161) 5×E-GFP or SV40 NLS-BSA-TRITC and 0.4 µM importin α. In the right-hand panels, import substrates were preincubated with 0.2 µM importin β before addition to the import assay. After 10 min incubation at 22°C, cells were fixed and nuclear uptake was assayed by confocal fluorescence microscopy. (b) Mitotic cell extract can stimulate nuclear import of the CRS. Permeabilised HeLa cells were incubated in interphase (S-phase) or M-phase HeLa cell extract and an energy-regenerating mixture with 3 µM cyclin B1(1-161)-GFP. After 10 min incubation at 37°C cells were fixed and nuclear uptake was assayed by confocal fluorescence microscopy. identified for the Pho4 transcription factor in budding yeast [28, 29] . Our studies have not conclusively identified the kinase responsible for phosphorylation of the CRS. Recombinant cyclin B1-Cdk1 purified from bacteria is able to phosphorylate the sites in the CRS -primarily on S126 -although we were unable to assay any difference in the translocation of S126A compared with the wild-type protein.
Meijer and colleagues have shown that autophosphorylation is the principal pathway for cyclin B1 phosphorylation in maturing starfish oocytes [20] . Thus it is possible that when cyclin B1-Cdk1 is activated at mitosis the complex will autophosphorylate and consequently translocate to the nucleus. However, this does not exclude the possibility that an initial 'trigger' kinase is also involved in the same way that polo-like kinase1 (Plk1) is thought to activate Cdc25C before its phosphorylation by cyclin B-Cdk1 as part of an autoamplification loop [30, 31] . Indeed, the NIMA kinase is required for nuclear localisation of cyclin B1 in the fungus Aspergillus nidulans [32] by a mechanism that may require the SONA nuclear transport protein.
Translocation of cyclin B1 to the nucleus at prophase is also likely to involve a reduction in its rate of nuclear export. Exportin 1/Crm1 binds less efficiently to Xenopus cyclin B1 in mitotic extracts, and a mutant cyclin B1 with glutamic acids replacing the serines in the CRS was exported much less efficiently from Xenopus oocytes [15] . We also found that the 5×A mutant of cyclin B1 was exported more rapidly from nuclei than the wild-type protein or the 5×E mutant (data not shown). Our data suggest that the primary change in the import behaviour of phosphorylated cyclin B1 at mitosis is the creation of a nuclear import signal in the amino terminus.
A mutant of Xenopus cyclin B1 lacking the amino terminus, including the CRS, has been shown to bind directly to importin β in interphase Xenopus extracts and be imported, although slowly, into nuclei [19] . We found that importin β had either no effect on, or slightly stimulated, the import of full-length cyclin B1-GFP in vitro. Cyclin B1 import in interphase might, therefore, be dependent on importin β. We do not believe that the phosphorylation-dependent NLS created on the CRS is recognised by importin β, however, because importin β was unable to stimulate the import of either the 5×E (Figure 7 ) or the wild-type amino terminus linked to GFP (data not shown). Similarly, neither importin α nor transportin were able to stimulate import, and import of the 5×E mutant was not markedly enhanced by the addition of cell extract (data not shown). The import receptor or carrier appears, therefore, to be associated with the nuclei or the permeabilised cells in the in vitro system.
Conclusions
The translocation of cyclin B1 to the nucleus begins at the end of prophase, after many of the nuclear events of mitosis are already underway or completed, including chromosome condensation and disassembly of the nucleoli. The rapid translocation of cyclin B1 is consequent on an increase in its rate of import as well as a probable decrease in its rate of export. The increase in nuclear import rate depends on phosphorylation of the CRS, and this creates a nuclear import signal in the amino terminus of cyclin B1 that can target an exogenous protein to the nucleus. The phosphorylation of the CRS is therefore key to the localisation of cyclin B1 at the beginning of mitosis.
Materials and methods

Cell culture and synchronization
HeLa cells were cultured on plates in DMEM supplemented with 10% calf serum at 37°C/10% CO 2 . Cells were synchronized using a thymidine and aphidicolin regime as previously described [33] . For M-phase extracts, cells were synchronised by release from a double thymidine block and arrested in mitosis with nocodazole as described [33] .
Construction of point mutants and chimaeras
Fusion proteins and point mutations were constructed by PCR using VENT polymerase (Biolabs), cloned into bacterial expression vectors, and sequenced on an automatic sequencer. pCMX-cyclin B1-MmGFP and pRSETB-cyclin B1(1-161)-MmGFP have been described previously [13] . pCMX-cyclin B1-MmGFP or pCMX-cyclin B1 was used as a template to change serine residues 116, 126, 128, 133 and 147 into alanine, glutamic acid or threonine residues using the overlap extension technique [34] . The cDNAs for the GST fusion proteins were cloned into pGEX-2T (Pharmacia) using a seven amino acid (SPGILDS) linker between GST and the start codon of cyclin B1. The stop codon of cyclin B1 was mutated to a XbaI site to link it to YFP using pEYFP (Clontech). The resulting plasmid was used for subcloning cyclin B1-YFP into pCMX. All other constructs described are subclones from these constructs. All sequences of primers used in this study are available on request.
Protein expression and purification
Full-length GST-cyclin B1, GST-cyclin-GFP and GG-NES proteins were expressed in E. coli C41 [35] . E. coli cells were grown at 37°C to OD 600 of ~0.5 and then induced for 6-8 h with 0.1 mM isopropylthiogalactoside (IPTG) at 20-25°C. Cells expressing the GST proteins were lysed by lysozyme and sonication. The proteins were purified using glutathione-Sepharose 4B beads (Pharmacia). Cyclin B1-GFP was cleaved from GST with thrombin (Sigma) according to the manufacturer's instructions. Fusion proteins between the amino terminus of cyclin B1 and MmGFP were expressed and purified as described [13] . For microinjections, proteins were concentrated in a Vivaspin 50000 MW cut-off microconcentrator (Vivascience), diluted ~300 times in 10 mM phosphate buffer pH 7.2 supplemented with 100 mM KCl, and concentrated again. Protein concentrations were assayed using Coomassie Plus Protein Assay Reagent (Pierce).
Preparation of HeLa cell extracts
HeLa cells were washed twice with ice-cold PBS. For M-phase cells, the medium was also collected and any detached cells washed by centrifugation (180 × g for 5 min at 4°C). Cells were detached from the dish using a cell scraper, and transferred to a 15 ml centrifuge tube. Cells were centrifuged at 180 × g for 5 min at 4°C. The cell pellet was resuspended in an equal volume of hypotonic lysis buffer (25 mM NaCl, 20 mM Hepes-KOH pH 7.4, 1 mM EDTA, 1 mM dithiothreitol (DTT), 10 µg/ml cytochalasin B, 1 mM phenylmethanesulfonyl fluoride (PMSF), protease inhibitor cocktail tablet (1 per 10 ml; Boehringer Mannheim), 1 mM Na 3 VO 4 , 5 mM NaF, 1 µM microcystin LR) and incubated on ice for 20 min before dounce homogenisation (~20 strokes). During homogenisation, the salt concentration was increased to 0.15 M NaCl. The cell extract was incubated at 4°C for 30 min on a rotating wheel, subsequently clarified by centrifugation at 16,000 × g for 5 min at 4°C, and kept on ice.
Isolation of proteins using a GST-cyclin B1 affinity matrix and in vitro kinase assays
HeLa cell extracts were first incubated with purified GST bound to glutathione-coated Sepharose beads (~0.25 mg/ml) to remove non-specifically binding proteins. GST-coated beads were pre-washed with bead buffer (150 mM NaCl, 20 mM Hepes-KOH pH 7.4, 1 mM EDTA, 1 mM DTT, 1 mM PMSF, protease inhibitor cocktail tablet (1 per 10 ml), 1 mM Na 3 VO 4 , 5 mM NaF) and incubated with extract (40 µl of beads per ml of extract) at 4°C for 30 min on a rotating wheel. The beads were pelleted (150 × g for 2 min), and the supernatant transferred to a fresh tube. Purified GST-cyclin B1 bound to glutathione-coated Sepharose beads (~0.25 mg/ml) was added to the supernatant (15 µl beads per ml extract) and incubated at 4°C for 2 h on a rotating wheel. The beads were pelleted and washed 3 times with 700 µl bead buffer at 4°C for 15 min on a rotating wheel. The beads were subsequently washed with 700 µl kinase buffer (150 mM NaCl, 20 mM Hepes-KOH pH 7.4, 10 mM MgCl 2 , 1 mM DTT, 1 mM Na 3 VO 4 , 5 mM NaF), and incubated with 10 µl of kinase reaction mixture (9.4 µl of kinase buffer; 0.3 µl of 1 mM ATP; 3.0 µCi of [γ-33 P]ATP) at 30°C for 30 min. Cyclin B1 was subsequently cleaved from the GST domain using thrombin. The samples were analysed by SDS-PAGE and autoradiography. For phosphoamino-acid analysis, the samples were transferred to Immobilon-P membrane after SDS-PAGE.
Phosphoamino-acid analysis
Cyclin B1 was excised from Immobilon-P membrane and two-dimensional phosphoamino-acid analysis carried out according to [36] .
Time-lapse fluorescence imaging
Cells were injected with cDNA (0.1 mg/ml unless indicated otherwise in the figure legend) or proteins using an Eppendorf semi-automatic microinjector attached to a Leica DMIRBE microscope. Cells were incubated in CO 2 -independent medium without phenol red (Gibco), and overlaid with mineral oil for long time courses, and maintained at 37°C using a ∆T 0.15 mm dish (Bioptechs). Cells were imaged by time-lapse fluorescence microscopy using custom filter sets (Chroma Technology), a PentaMax camera (Princeton Instruments) and a Lambda 10-2 filter wheel (Sutter) controlled by a PowerWave computer (PowerComputing) running IP Lab Spectrum software (Scanalytics) as described [37] . To distinguish GFP and YFP fluorescence, we used a PentaMax camera with a Gen IV intensifier (Princeton Instruments) and a custom filterset JP3 (Ex: D460/20, HQ523/20, Em: D500/22, HQ568/50, Chroma Technology). To check for nuclear envelope breakdown, Texas-Red-conjugated dextran, 70,000 Da (Molecular Probes) was injected into the cytoplasm.
In vitro nuclear import assay
Nuclear import assays were carried out as described [38] . Import reactions were started by adding digitonin-permeabilised HeLa cells synchronised to mid-S-phase to the following reaction mixture: 20 mM Hepes-KOH pH 7.5, 150 mM potassium acetate, 3 mM magnesium acetate, 250 mM sucrose, an energy-regenerating mixture (1 mM ATP, 100 µM GTP, 10 mM creatine phosphate, 50 µg/ml creatine kinase), 0.5 µM RanGDP, 0.5 µM NTF2 and 5 mg/ml BSA, or synchronised HeLa cell extract supplemented with energy-regenerating mixture. Nuclear import substrates were used at 3 µM. Relative concentrations of GFP-tagged substrates were also measured by comparing their fluorescence using a Perkin Elmer Fluorimeter. Nuclei were incubated for 10 min at 22°C or 37°C, fixed with 4% paraformaldehyde and centrifuged through a 30% sucrose cushion onto polylysine-coated coverslips. Nuclear import was assayed by laser scanning confocal microscopy using a Bio-Rad 1024 confocal microscope, and the relative amounts of fluorescent substrate imported were measured using the Laser Sharp program (Bio-Rad) and IPLab Spectrum (Scanalytics).
